Atlas Trials

Validation of ERTugliflozin for Inhibiting Cardiac Fibrosis Using Cardiac MRI and Laboratory Parameters in Korean Heart Failure Patients With Nonischemic Cardiomyopathy(VERTICAL)

Clinical trial NCT04490681 · UNKNOWN

Trial details

NCT number
NCT04490681
Sponsor
Yonsei University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Heart Failure With Nonischemic Cardiomyopathy
Start date
2020-08-01
Primary completion
2021-12-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.